The reasonableness of the choice of CGCs as an experimental model is based on the fact that during the onset of the apoptosis of CGCs, several molecular events evocative of AD are induced, such as the activation of the amyloidogenic process, the splitting of Tau with the production of toxic fragments (see [248] and references therein), as well as mitochondrial dysfunction. Here, MAPT is linked to Alzheimer disease.